InvestSMART

Invex Therapeutics Ltd (ASX: IXC) - Announcements

- Current share price for IXC : $0.110

ASX company news and announcements for Invex Therapeutics Ltd (IXC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Invex Therapeutics Ltd (IXC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Invex Therapeutics Ltd (IXC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Invex Therapeutics Ltd (IXC)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$8 Conference Call Recording 24 Jul 2020 12:43PM $1.010 $0.110 fallen by 89.11%
$8 Quarterly Report and Appendix 4C 24 Jul 2020 8:18AM $0.990 $0.110 fallen by 88.89%
$8 Initial FDA and EMA Advice on Presendin Development 23 Jul 2020 9:22AM $1.140 $0.110 fallen by 90.35%
$8 Trading Halt 22 Jul 2020 9:26AM $1.140 $0.110 fallen by 90.35%
$8 Notice of Allowance for Key US Exenatide Patent 21 Jul 2020 9:21AM $1.105 $0.110 fallen by 90.05%
$8 Ceasing to be a substantial holder 3 Jul 2020 9:09AM $1.290 $0.110 fallen by 91.47%
$8 Change of Director's Interest Notice 3 Jul 2020 8:19AM $1.290 $0.110 fallen by 91.47%
$8 Appendix 2A 3 Jul 2020 8:19AM $1.290 $0.110 fallen by 91.47%
$8 Constitution 30 Jun 2020 9:16AM $1.270 $0.110 fallen by 91.34%
$8 Results of Meeting 30 Jun 2020 8:16AM $1.270 $0.110 fallen by 91.34%
$8 Presentation of Exenatide Phase II Data at Headache Congress 29 Jun 2020 9:26AM $1.300 $0.110 fallen by 91.54%
$8 Change in substantial holding 2 Jun 2020 3:35PM $1.465 $0.110 fallen by 92.49%
$8 Ceasing to be a substantial holder 2 Jun 2020 11:27AM $1.460 $0.110 fallen by 92.47%
$8 Change of Director's Interest Notice 2 Jun 2020 11:26AM $1.460 $0.110 fallen by 92.47%
$8 Postcard to Shareholders - General Meeting 28 May 2020 7:27PM $1.450 $0.110 fallen by 92.41%
$8 Notice of General Meeting/Proxy Form 28 May 2020 7:20PM $1.450 $0.110 fallen by 92.41%
$8 Change in substantial holding 28 May 2020 1:55PM $1.450 $0.110 fallen by 92.41%
$8 Ceasing to be a substantial holder 28 May 2020 12:36PM $1.450 $0.110 fallen by 92.41%
$8 Change in substantial holding 28 May 2020 12:28PM $1.450 $0.110 fallen by 92.41%
$8 Change in substantial holding 28 May 2020 11:58AM $1.460 $0.110 fallen by 92.47%
$8 Issue of Tranche 1 Placement Shares and Appendix 2A 28 May 2020 8:47AM $1.530 $0.110 fallen by 92.81%
$8 Proposed issue of Securities - IXC 22 May 2020 9:40AM $1.495 $0.110 fallen by 92.64%
$8 Proposed issue of Securities - IXC 22 May 2020 9:40AM $1.495 $0.110 fallen by 92.64%
$8 Phase II Clinical Results and Capital Raising Presentation 22 May 2020 9:40AM $1.495 $0.110 fallen by 92.64%
$8 Succesful $26 million Share Placement 22 May 2020 9:40AM $1.495 $0.110 fallen by 92.64%

226 - 250 of 300 results

Page 10 of 12

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.